Trial With HuMax-CD4 in Participants With Rheumatoid Arthritis (RA) Failing Treatment With Methotrexate (MTX) and a TNF-alpha Blocker

Clinical trial NCT00042406 · TERMINATED

Trial details

NCT number: NCT00042406
Sponsor: Genmab
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2002-03-04
Primary completion: 2003-03-31
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.